| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.025 | 0.4 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.4 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | -0.036 | 0.4 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.041 | 0.4 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |